Cetera Advisors LLC decreased its position in Corteva, Inc. (NYSE:CTVA – Get Rating) by 9.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 17,954 shares of the company's stock after selling 1,930 shares during the quarter. Cetera Advisors LLC's holdings in Corteva were worth $972,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CTVA. Vanguard Group Inc. grew its position in shares of Corteva by 1.6% in the first quarter. Vanguard Group Inc. now owns 80,762,837 shares of the company's stock valued at $4,642,248,000 after purchasing an additional 1,275,514 shares during the period. BlackRock Inc. increased its stake in shares of Corteva by 2.5% during the 1st quarter. BlackRock Inc. now owns 61,242,962 shares of the company's stock valued at $3,520,247,000 after acquiring an additional 1,483,373 shares during the last quarter. State Farm Mutual Automobile Insurance Co. lifted its holdings in shares of Corteva by 1.5% during the 2nd quarter. State Farm Mutual Automobile Insurance Co. now owns 7,402,903 shares of the company's stock worth $400,793,000 after acquiring an additional 108,923 shares during the period. Boston Partners boosted its position in shares of Corteva by 1.3% in the first quarter. Boston Partners now owns 7,351,215 shares of the company's stock worth $422,568,000 after acquiring an additional 91,847 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in Corteva by 4.0% in the first quarter. Bank of New York Mellon Corp now owns 7,087,282 shares of the company's stock valued at $407,375,000 after purchasing an additional 272,159 shares during the period. 79.02% of the stock is currently owned by hedge funds and other institutional investors.

Get Corteva alerts:

Corteva Trading Up 0.8 %

CTVA opened at $66.33 on Friday. The stock has a market capitalization of $47.39 billion, a PE ratio of 35.47, a P/E/G ratio of 1.61 and a beta of 0.74. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.08. Corteva, Inc. has a 12-month low of $43.74 and a 12-month high of $68.43. The firm's fifty day moving average price is $62.96 and its 200 day moving average price is $59.66.

Corteva (NYSE:CTVA – Get Rating) last issued its earnings results on Friday, November 4th. The company reported ($0.12) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.11. The business had revenue of $2.78 billion for the quarter, compared to analyst estimates of $2.58 billion. Corteva had a net margin of 7.95% and a return on equity of 7.31%. The company's revenue for the quarter was up 17.1% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.14) EPS. As a group, research analysts expect that Corteva, Inc. will post 2.57 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 15th. Stockholders of record on Monday, November 14th will be issued a $0.15 dividend. The ex-dividend date is Thursday, November 10th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.90%. Corteva's dividend payout ratio (DPR) is 32.09%.

Corteva declared that its board has approved a stock buyback plan on Tuesday, September 13th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to purchase up to 4.3% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's management believes its shares are undervalued.

Analyst Ratings Changes

A number of brokerages have weighed in on CTVA. BMO Capital Markets lifted their price target on shares of Corteva from $72.00 to $76.00 and gave the company an "outperform" rating in a report on Monday, November 7th. Mizuho lifted their target price on Corteva from $74.00 to $76.00 and gave the company a "buy" rating in a report on Monday, November 7th. UBS Group lowered Corteva from a "buy" rating to a "neutral" rating and upped their price target for the stock from $70.00 to $73.00 in a research note on Tuesday, November 15th. Loop Capital lowered Corteva from a "buy" rating to a "hold" rating and lifted their price objective for the company from $70.00 to $71.00 in a research note on Tuesday, November 15th. Finally, Barclays raised their price target on shares of Corteva from $71.00 to $75.00 and gave the company an "overweight" rating in a report on Thursday, November 17th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat, Corteva has an average rating of "Moderate Buy" and an average target price of $71.93.

Insider Activity at Corteva

In other Corteva news, insider Audrey Grimm sold 10,000 shares of the business's stock in a transaction on Thursday, September 15th. The shares were sold at an average price of $62.79, for a total transaction of $627,900.00. Following the completion of the sale, the insider now owns 7,511 shares in the company, valued at $471,615.69. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.08% of the company's stock.

Corteva Profile

(Get Rating)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Featured Articles

• Get a free copy of the StockNews.com research report on Corteva (CTVA)
• MarketBeat: Week in Review 11/21 – 11/25
• Institutional Support for Analog Devices Remains High
• Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
• Three CBD Stocks to Dominate a Budding Industry
• Microsoft Shares: Is it Time to Back Up the Truck?

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Get Rating).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.